Hey Captain Scotty,
I own TXTM and I am considering purchasing PLPL again but I am confused about the relationship with TXTM (see quote below from PR).
“Protext, which is an affiliate company of Plandaí with Plandai owning a significant equity stake (60%), owns the exclusive license to create a pharmaceutical cannabis extract using our proprietary extraction process.”
For clarification:
Does PLPL own 60% of TXTM?
PLPL owns the patent?
TXTM owns the exclusive license to the patent? Do you know if TXTM paid a one time fee? Does TXTM pay a monthly or yearly fee? Or perhaps a percentage of revenue from sales of developed products?
I may sell some of my TXTM and buy PLPL.
Regards,
Joe